DescriptionStem cells are responsible for tissues to regenerate, remodel and function in a normal physiological milieu and thus offer a highly attractive approach forcell replacement therapy. Embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC) hold the potential to generate virtually every cell type of our body, and within the last decade the regenerative capacity of adult stem cells have been widely exploited, e.g. to generate tissues like blood vessels, bone, cartilage and more complex organs such as liver, intestine and heart. Particularly in the field of tissue engineering, research into developing the correct biomaterials and tissue-specific scaffolds have been given a tremendous push forward and with our increased understanding of fundamental stem cell biology, stem cell-based treatments and drug screening of patients is within reach. These translational stem cell activities are key to realizing the promise of stem cells for future clinical treatments and research groups and companies around the world are already pursuing clinical trials based on stem cells.
|Period||4 Jun 2015 → 5 Jun 2015|